Imaging of Liver

On this page

Liver Imaging Toolkit - Modality Mania

  • USG (Ultrasound): Initial, non-invasive. Assesses size, echotexture, focal lesions (cysts, solid), steatosis. Doppler for vascularity.
  • CT (Computed Tomography): Workhorse. Non-contrast (fat, $Ca^{2+}$, blood).

    Typical Liver Triphasic CT Enhancement:

    • Arterial Phase (~25-35s): Hypervascular lesions (HCC, FNH, adenoma, hemangioma [peripheral]).
    • Portal Venous Phase (~60-80s): Peak parenchymal enhancement; most metastases.
    • Delayed Phase (~3-5+ min): Washout (HCC); delayed enhancement (cholangiocarcinoma, hemangioma [centripetal fill-in]).
  • MRI (Magnetic Resonance Imaging): Superior soft-tissue contrast. Problem-solving. Sequences: T1, T2, DWI, hepatobiliary agents.
  • Elastography: Assesses liver stiffness (fibrosis).

Liver Steatosis MRI: In-phase, Out-of-phase, PDFFoka

Benign Bumps - Friendly Formations

  • Hemangioma: Most common benign lesion.

    • US: Hyperechoic. CT/MRI: Peripheral, discontinuous, nodular enhancement; centripetal fill-in.

    ⭐ Hemangiomas typically show peripheral, discontinuous, nodular enhancement that fills in centripetally on dynamic contrast-enhanced CT/MRI.

  • Focal Nodular Hyperplasia (FNH):

    • Arterial: Intense, homogeneous enhancement (scar may not).
    • Central scar: T2 bright, delayed enhancement.
    • Gadoxetate: Uptake (vs. adenoma).
  • Hepatic Adenoma:

    • OCP/steroid link. Risk: Hemorrhage, malignant change (rare).
    • Heterogeneous (fat/bleed). Arterial enhancement.
    • Gadoxetate: Usually no uptake.
  • Simple Cyst:

    • US: Anechoic. CT: 0-20 HU (water). T2: Markedly bright. No enhancement.

Malignant Masses - Nasty Newcomers

  • Hepatocellular Carcinoma (HCC): Most common primary. Risks: Cirrhosis, HBV, HCV.

    ⭐ HCC: Classic arterial phase hyperenhancement (APHE) & portal/delayed washout (LI-RADS major feature).

    • Other features: Capsule, mosaic pattern.
  • Cholangiocarcinoma (CCC): Intrahepatic or perihilar. Features: Delayed enhancement, capsular retraction, biliary dilatation.
  • Metastases: Most common liver malignancy overall. Appearance varies.
    • Hypovascular: e.g., Colorectal.
    • Hypervascular: e.g., NET, RCC, Melanoma. 📌 Mnemonic (Hypervascular): Melanoma, RCC, NET, Thyroid (MR. NT).
  • LI-RADS: Standardizes HCC risk reporting (e.g., LR-5 for definite HCC).

MRI Liver: APHE, Washout, and LR-5 HCC

Sick Spreads - Diffuse Dilemmas

  • Cirrhosis:

    ⭐ Imaging: Nodular surface, caudate hypertrophy, portal hypertension (splenomegaly, varices, ascites).

    • Fibrosis, regenerative nodules. Complications: HCC.
  • Hepatic Steatosis (Fatty Liver):
    • US: ↑ Echogenicity (bright liver).
    • CT: ↓ Attenuation (< 40 HU, or < spleen by 10 HU).
    • MRI: Signal loss on out-of-phase imaging.
  • Hemochromatosis (Iron Overload):
    • CT: ↑ Liver density.
    • MRI: ↓ T2/T2* signal intensity (paramagnetic effect).
  • Wilson's Disease (Copper):
    • Variable: cirrhosis, steatosis, acute hepatitis. Ultrasound: Cirrhosis with ascites

Vascular & Trauma - Flow & Fracture

  • Budd-Chiari Syndrome (BCS): Hepatic vein obstruction. CT/MRI: hepatomegaly, ascites, caudate hypertrophy, patchy enhancement ("nutmeg liver").

    ⭐ Budd-Chiari syndrome imaging often reveals hepatomegaly, ascites, and characteristic 'nutmeg liver' or 'flip-flop' enhancement pattern of the caudate lobe due to its separate venous drainage.

  • Portal Vein Thrombosis (PVT): Portal vein clot. US/CT: filling defect, cavernous transformation (chronic).
  • Liver Trauma (CT is key):
    • Lacerations: Graded (AAST).
    • Hematomas: Subcapsular, intraparenchymal.
    • Active bleed: Contrast extravasation. CT scan: Liver laceration with active contrastoka

High‑Yield Points - ⚡ Biggest Takeaways

  • HCC: Key features are arterial phase hyperenhancement and subsequent portal venous/delayed phase washout.
  • Liver Metastases: Most common malignant liver tumor; imaging appearance is highly variable.
  • Hemangioma: Most common benign liver tumor; shows peripheral nodular enhancement with centripetal fill-in.
  • FNH: Often presents with a central scar; demonstrates intense, homogeneous arterial enhancement.
  • Cirrhosis: Imaging signs include nodular liver surface, caudate lobe hypertrophy, and portal hypertension.
  • Hydatid Cyst: Characterized by pathognomonic daughter cysts or the "water lily sign".
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Imaging of Liver

Test your understanding with these related questions

What is the next best step for a 22-year-old with a hepatic hemangioma on ultrasound?

1 of 5

Flashcards: Imaging of Liver

1/10

HCCs often appears _____vascular during the arterial phase of computed tomography (CT) studies

Hint: hypo/hyper

TAP TO REVEAL ANSWER

HCCs often appears _____vascular during the arterial phase of computed tomography (CT) studies

hyper

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free
Imaging of Liver - Free Indian Medical PG High-Yield Review